Fundraising FoxCodon Capital — 2019 Investments
1 investments dated 2019 · listed companies and verified rows first · show all
Good Therapeuticsgoodtherapeutics.com𝕏Series A · Feb 2019 · $11Macquired by Roche
Portfolio company acquired by Roche.
BiotechSeattle, US
John Mulligan(Executive Officer, Director, Promoter)inMitchell Mutz(Director)Nicholas Walrod(Director)
BoardJohn McKearn(Director)inKarl Handelsman(Director)
Co-investorsDigitalis VenturesRiverVest Venture PartnersRoche Venture Fund
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.